This inventor holds 10 USPTO granted patents. Top assignee: Genzyme Corporation. Active years: 2005-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2009
Title: Mukund K Gurjar: Innovator in Amino Acid Synthesis
Introduction
Mukund K Gurjar is a prominent inventor based in Pune, India. He has made significant contributions to the field of chemistry, particularly in the synthesis of amino acids and iron chelating agents. With a total of 10 patents to his name, Gurjar's work has paved the way for advancements in pharmaceutical applications.
Latest Patents
Gurjar's latest patents include innovative methods for synthesizing non-natural amino acids, specifically 2-alkyl amino acids. These compounds allow for the creation of a broader range of peptidal and non-peptidal pharmaceutically active agents. One of his notable inventions involves a Michael-type addition of a nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate, which subsequently converts an ester moiety into an amino moiety. Additionally, he has developed methods for preparing iron chelating agents related to desferrithiocin, which contain a thiazoline ring. Another significant patent focuses on the synthesis of a 4-methylthiazole-4(S)-carboxylic acid compound, showcasing a facile synthesis for ethyl 2,4-dihydroxybenzimidate from 2,4-dihydroxybenzoic acid.
Career Highlights
Gurjar is currently associated with Genzyme Corporation, where he continues to innovate and contribute to the field of biochemistry. His work has been instrumental in advancing the understanding and application of amino acids in pharmaceuticals.
Collaborations
Some of his notable coworkers include Mukund Shankar Chorghade and Joseph Cherian, who have collaborated with him on various projects, enhancing the scope and impact of their research.
Conclusion
Mukund K Gurjar's contributions to the field of amino acid synthesis and iron chelation have established him as a key figure in the scientific community. His innovative patents reflect a commitment to advancing pharmaceutical science and improving therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
